Most Read Articles
6 days ago
Girls with eosinophilic oesophagitis (EoE) who show initial response to directed therapy will tend to continue to respond well to treatment, a recent study has shown.
Pearl Toh, 4 days ago
Adding a LAMA* to the double combination therapy of ICS** plus LABA*** in a single inhaler improves lung function and reduces exacerbations in patients whose asthma is inadequately controlled with the combination treatment, according to the TRIMARAN and TRIGGER# studies presented at ERS 2019.
Elvira Manzano, 5 days ago
Final overall survival (OS) results from the double-blind phase III FLAURA study reinforce osimertinib as the standard frontline treatment for epidermal growth factor receptor-mutated (EGFRm) non–small cell lung cancer (NSCLC), say leading oncologists at ESMO 2019.
Tristan Manalac, 4 days ago
Babies born to mothers exposed to high levels of bisphenol A during pregnancy are at a greater risk of wheezing and poor lung function, according to a new study presented at the recently concluded International Congress of the European Respiratory Society (ERS 2019).

Ginkgo biloba extract improves cognition and overall condition after ischaemic stroke

Christina Lau
23 Nov 2018
Dr Yanxin Zhao speaking at VasCog 2018

Use of a ginkgo biloba extract on top of standard preventive treatment is shown to improve cognitive function and overall condition after acute ischaemic stroke. 

In a multicentre pilot study, patients aged ≥50 years (n=201) who had an ischaemic stroke 7–14 days before baseline were randomized to receive standard treatment for prevention of stroke recurrence with or without EGb 761, a ginkgo biloba extract taken three times daily, for 24 weeks.

“Results showed significant improvements in cognitive function, mainly in memory, language, orientation and processing speed, in the EGb 761 vs standard treatment group, as assessed by Montreal Cognitive Assessment [MoCA] and Hopkins Verbal Learning Test [HVLT],” reported investigator Dr Yanxin Zhao of Fudan University, Shanghai, China, at VasCog 2018.

“Eighty percent of patients in the EGb 761 group had very much or much improved overall condition, compared with 20 percent of patients in the standard treatment group [p<0.05]. Neuropsychiatric symptoms and stroke-related symptoms were very mild at baseline, and improved slightly and to similar degrees in both groups,” he continued. “EGb 761 was safe and well tolerated in the study.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Girls with eosinophilic oesophagitis (EoE) who show initial response to directed therapy will tend to continue to respond well to treatment, a recent study has shown.
Pearl Toh, 4 days ago
Adding a LAMA* to the double combination therapy of ICS** plus LABA*** in a single inhaler improves lung function and reduces exacerbations in patients whose asthma is inadequately controlled with the combination treatment, according to the TRIMARAN and TRIGGER# studies presented at ERS 2019.
Elvira Manzano, 5 days ago
Final overall survival (OS) results from the double-blind phase III FLAURA study reinforce osimertinib as the standard frontline treatment for epidermal growth factor receptor-mutated (EGFRm) non–small cell lung cancer (NSCLC), say leading oncologists at ESMO 2019.
Tristan Manalac, 4 days ago
Babies born to mothers exposed to high levels of bisphenol A during pregnancy are at a greater risk of wheezing and poor lung function, according to a new study presented at the recently concluded International Congress of the European Respiratory Society (ERS 2019).